Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone IM/Oral in Acute Schizophrenia/Schizoaffective Disorder
NCT00650429Phase 4Completed
- Sponsor
- Viatris
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ziprasidone in schizophrenia and schizoaffective disorder, sponsored by Viatris. Primary endpoint: Brief Psychiatric Rating Scale at Week 6. Started Oct 2003; status: completed.
02
Drugs
ziprasidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00650429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00650429.